Sort
51,593 grants matching “hepatitis”
Maternal effect on offspring immunity against hepatitis B virus
$641,683J.-H. James Ou · University Of Southern California · R01 · FY2022 · AI
Maternal effect on offspring immunity against hepatitis B virus
$641,683J.-H. James Ou · University Of Southern California · R01 · FY2021 · AI
Maternal effect on offspring immunity against hepatitis B virus
$641,683J.-H. James Ou · University Of Southern California · R01 · FY2019 · AI
Maternal effect on offspring immunity against hepatitis B virus
$641,683J.-H. James Ou · University Of Southern California · R01 · FY2023 · AI
Maternal effect on offspring immunity against hepatitis B virus
$641,683J.-H. James Ou · University Of Southern California · R01 · FY2020 · AI
An Antisense Design and Simulation Platform
$641,645Norm Earl Watkins · Dna Software, Inc. · R44 · FY2012 · GM
Phase II trial of tesamorelin for cognition in aging HIV-infected persons
$641,612Ronald J. Ellis · University Of California, San Diego · R01 · FY2016 · AG
Injection Risk Networks in Rural Puerto Rico
$641,575Kirk Dombrowski · University Of Nebraska Lincoln · R01 · FY2014 · DA
Statin Therapy for patients with compensated Cirrhosis
$641,566Elliot Tapper · University Of Michigan At Ann Arbor · U01 · FY2022 · DK
Quantitative studies of metabolic organ dynamics
$641,403Richard N. Bergman · Cedars-Sinai Medical Center · R01 · FY2020 · DK
Police Training to Reduce Occupational Needlesticks and HIV among Substance Users
$641,364Steffanie A Strathdee · University Of California, San Diego · R01 · FY2016 · DA
EFFICACY AND SAFETY OF A KETOGENIC DIET IN TYPE 1 DIABETES
$641,303Samuel Klein · Washington University · R01 · FY2024 · DK
Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease
$641,276Rheem Angela Totah · University Of Washington · R01 · FY2024 · HL
Persistent hepatitis C virus replication and immunity in pregnancy
$641,271Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2018 · AI
Optimization of Efficacy and Safety Pharamacology of Fibrosis Imaging Agent CM-65
$641,247Himashinie Diyabalanage · Collagen Medical, Llc · R44 · FY2014 · DK
Optimization of Substituted Phenoxyalkyl Pyridinium Oximes as Therapies for Organophosphate Poisoning
$641,224Janice E. Chambers · Mississippi State University · U01 · FY2025 · NS
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska
$641,174Robert L Carithers · University Of Washington · U01 · FY2010 · DK
Functional Interactions Between Lipoproteins and Protease Inhibitors in Atherosclerosis
$641,168Scott M Gordon · University Of Kentucky · R01 · FY2024 · HL
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
$641,161Frances Eun-Hyung Lee · Emory University · U01 · FY2020 · AI
Hepatotoxic effects of perfluoroalkyl substances: a new epidemiological approach for studying environmental fatty liver disease
$641,109Vaia Lida Chatzi · University Of Southern California · R01 · FY2021 · ES
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS
$641,103Arun J Sanyal · Virginia Commonwealth University · U01 · FY2007 · DK
Translational Project
$640,995Ashwin Balagopal · Johns Hopkins University · U19 · FY2025 · AI
Understanding the Multilevel Drivers of Liver Cancer Disparities
$640,962Salma Shariff-Marco · University Of California, San Francisco · R01 · FY2021 · CA
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
$640,903Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DK
Community-based interventions to reduce mortality from neonatal infection
$640,876Waldemar A. Carlo · University Of Alabama At Birmingham · U01 · FY2009 · HD